Lumos Pharma (LUMO) and Double Point Ventures announced the completion of the previously announced tender offer for Lumos Pharma’s shares at a purchase price of $4.25 per share in cash at ...
Lumos Pharma, Inc. and Double Point Ventures LLC announced the completion of a tender offer for Lumos Pharma's shares, with a purchase price of $4.25 per share in cash and one contingent value ...
TipRanks on MSN2mon
Lumos Pharma Faces Uncertainty as CVRs Risk Expiring Worthless Post-MergerLumos Pharma, Inc. (LUMO) has disclosed a new risk, in the Share Price & Shareholder Rights category. Lumos Pharma, Inc.
Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases. Lumos Pharma was founded and is led by a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback